📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Repurposing of Cetuximab in antibody-directed chemotherapy-loaded nanoparticles in EGFR therapy-resistant pancreatic tumours. (2019)

First Author: McDaid WJ

Attributed to: The Queen’s University of Belfast Confidence in Concept programme 2016 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1039/c9nr07257h

PubMed Identifier: 31626255

Publication URI: http://europepmc.org/abstract/MED/31626255

Type: Journal Article/Review

Volume: 11

Parent Publication: Nanoscale

Issue: 42

ISSN: 2040-3364